|
Design Considerations for Evaluating the Impact of PEPFAR
Monday, April 30—Tuesday, May 1, 2007
U. S. Institute of Medicine (IOM), Washington, DC
Keck Building, 500 Fifth Street NW, Room 100
Purpose: To discuss methodological, policy, and practical design considerations from the three main perspectives on accountability:
- “Upward”—Congress
- “Horizontal”—Global Partners/Coordination
- “Downward”—Country Partners/Harmonization
The workshop was moderated by Ruth Levine, Director of Programs and Senior Fellow, Center for Global Development.
Portions of the workshop were webcast thanks to the Kaiser Family Foundation and are available http://www.kaisernetwork.org/healthcast/iom/30apr07
A workshop summary will be published in a few months.
Monday, April 30, 2007—Perspectives on Evaluation
9:00 – 9:05 Welcome
Michele Orza, ScD
Study Director, PEPFAR Implementation Evaluation
U. S. Institute of Medicine
9:10 – 9:15 Introduction and Framing the Issues
Ruth Levine, PhD
Director of Programs and Senior Fellow
Center for Global Development
9:15 – 10:15 Congressional Perspective
Purpose: To understand what Congress wants/needs to learn from impact evaluation, discuss the evaluation language in the Leadership Act
Savannah Lengsfelder, MA
Legislative Assistant
Senate Committee on Foreign Relations, Subcommittee on African Affairs
Christos Tsentas
Senior Legislative Assistant
Congresswoman Barbara Lee
David Gootnick, MD
Director, International Affairs and Trade
U. S. Government Accountability Office
Allen Moore, MBA
Senior Fellow, Global Health Council
Senior Associate, Center for Strategic and International Studies
Jim Sherry, MD, PhD (Discussant)
Subcommittee Member, IOM Evaluation of PEPFAR Implementation
Professor and Chair, Department of Global Health
George Washington University
10:15 – 11:15 PEPFAR Perspective
Purpose: To understand the U.S. Global AIDS Coordinator’s overall strategy for monitoring and evaluation, how impact evaluation fits into it, what program officials need/want to learn from impact evaluation, how they plan to coordinate and harmonize
Tom Kenyon, MD, MPH
Presentation
Principal Deputy U. S. Global AIDS Coordinator
Chief Medical Officer
Office of the U. S. Global AIDS Coordinator
Kathy Marconi, PhD, MS
Presentation
Director of Monitoring, Evaluation, and Strategic Information
Office of the U. S. Global AIDS Coordinator
Shannon Hader, MD
Presentation
Senior Scientific Advisor
Office of the U. S. Global AIDS Coordinator
11:15 – 11:30 Break
11:30 – 1:00 Perspectives of Global Partners
Purpose: To get the perspective of other donors with which the U.S. should be coordinated with respect monitoring and evaluation
Paul R. De Lay, MD
Presentation
Director, Monitoring and Evaluation
The Joint United Nations Programme on HIV/AIDS
Jody Kusek, PhD
Lead Monitoring and Evaluation Specialist, Global HIV/AIDS Program
The World Bank
Julia Compton, PhD
Senior Evaluation Manager, Evaluation Department
U. K. Department for International Development
Ambassador Jimmy Kolker (Discussant)
Deputy U. S. Global AIDS Coordinator
Office of the U. S. Global AIDS Coordinator
Jim Sherry, MD, PhD (Discussant)
Subcommittee Member, IOM Evaluation of PEPFAR Implementation
Professor and Chair, Department of Global Health
George Washington University
1:00 – 1:30 Break to Get Lunch
1:30 – 2:15 Luncheon Speaker and Discussion
“Monitoring and Evaluating Fairness in Scaling-up ART”
Norman Daniels, PhD
Presentation
Professor of Ethics and Population Health
Harvard School of Public Health
2:15 – 4:15 Perspectives of Implementers and Country Partners
Purpose: To get the perspective of various partners and stakeholders in the impact evaluation—the focus countries, program implementers, other programs with which the U.S. should be harmonized with respect to monitoring and evaluation, advocacy groups
Agnes Binagwaho, MD
Presentation
Executive Secretary
Rwanda National AIDS Control Commission
Jonathan Mwiindi
Presentation
Director, Kijabe HIV/AIDS Relief Program, Kenya
HIV/AIDS Program Officer
Ecumenical Pharmaceutical Network
Nils Daulaire, MD, MPH
President and CEO
Global Health Council
Mary Lyn Field-Nguer, MSN, FNP
Presentation
Director, Global HIV/AIDS programs/Washington
John Snow, Inc.
Kent Glenzer, PhD
Director, Impact Measurement and Learning Team
CARE USA
Sara Pacque-Margolis, MPH
Presentation
Director, Monitoring and Evaluation
Elizabeth Glaser Pediatric AIDS Foundation
4:15 – 4:30 Break
4:30 – 5:45 Combined Panel
Moderated discussion with all panelists and audience
Tuesday, May 1, 2007—Evaluation Design Challenges and Solutions
Purpose: To benefit from the experience of people who have evaluated or are currently evaluating programs that have major elements in common with the U.S. Global AIDS Initiative
9:00 – 11:00 Design Lessons Learned from Evaluating Donor Programs
(Macro-, Meso-, Micro-level)
Phillip Nieburg, MD, MPH (Moderator/Discussant)
Senior Associate and Co-chair
Prevention Committee, HIV/AIDS Task Force
Center for International and Strategic Studies
Jaime Sepulveda, MD, DrSc
Presentation
Chair, IOM Committee on PEPFAR Evaluation
Visiting Professor and 2007 Presidential Chair
University of California, San Francisco
Martha Ainsworth, PhD
Presentation
Lead Economist and Coordinator
Health and Education Evaluation Independent Evaluation Group
The World Bank
Rachel Glennerster, PhD
Presentation
Executive Director
Abdul Latif Jameel Poverty Action Lab
Julia Compton, PhD
Presentation
Senior Evaluation Manager, Evaluation Department
U. K. Department for International Development
Kent Glenzer, PhD
Director, Impact Measurement and Learning Team
CARE USA
Stefano Bertozzi, MD, PhD
Member, IOM Committee for Evaluation of PEPFAR Implementation
Member, The Technical Evaluation Reference Group – Global Fund
Director, Division of Health Economics and Policy
National Institute of Public Health, Mexico
Jim Sherry, MD, PhD (Discussant)
Subcommittee Member, IOM Evaluation of PEPFAR Implementation
Professor and Chair, Department of Global Health
School of Public Health and Health Services
George Washington University
11:00 – 11:15 Break
11:15 – 1:15 Methodological Challenges (Meso-, Micro-level)
Purpose: Discuss critical methodological issues and approaches for addressing them
Focus: Evaluation of key AIDS-specific outcomes and impacts
Paul R. De Lay, MD
Director, Monitoring and Evaluation
The Joint United Nations Programme on HIV/AIDS
Theresa Diaz-Vargas, MD, MPH
Presentation
Branch Chief, Epidemiology and Strategic Information
Global AIDS Program, U. S. Centers for Disease Control and Prevention
Geoff Garnett, PhD
Presentation
Member, IOM Committee for Evaluation of PEPFAR Implementation
Professor of Microparasite Epidemiology
Imperial College
William L. Holzemer, RN, PhD, FAAN
Presentation
Member, IOM Committee for Evaluation of PEPFAR Implementation
Professor and Associate Dean, International Programs, School of Nursing
University of California, San Francisco
Rand Stoneburner, MD, MPH
Presentation
Independent Consultant
Agnes Binagwaho, MD (Discussant)
Executive Secretary
Rwanda National AIDS Control Commission
Timothy Fowler, MA (Discussant)
Chief, Health Studies Branch, International Programs
U. S. Census Bureau
Rachel Glennerster, PhD
Executive Director
Abdul Latif Jameel Poverty Action Lab
Caroline Ryan, MD, MPH (Discussant)
Chief Technical Officer
Office of the U. S. Global AIDS Coordinator
1:15 – 2:00 Lunch Break
2:00 – 4:00 More Methodological Lessons/Challenges (Meso-, Micro-level)
Purpose: Discuss critical methodological issues and approaches for addressing them
Focus: Evaluation of key outcomes and impacts that are not AIDS-specific
Stefano Bertozzi, MD, PhD
Presentation
Member, IOM Committee for Evaluation of PEPFAR Implementation
Director, Division of Health Economics and Policy
National Institute of Public Health, Mexico
William L. Holzemer, RN, PhD, FAAN
Presentation
Member, IOM Committee for Evaluation of PEPFAR Implementation
Professor and Associate Dean, International Programs, School of Nursing
University of California, San Francisco
Carl Latkin, MS, PhD
Presentation
Subcommittee Member, IOM Evaluation of PEPFAR Implementation
Professor, Department of Health Policy and Management
Johns Hopkins School of Public Health
John Novak, PhD
Presentation
Senior Monitoring & Evaluation Advisor, Office of HIV/AIDS
United States Agency for International Development
Jessica E. Price, PhD
Presentation
Country Director, Rwanda
Family Health International
Julie Pulerwitz, ScD
Presentation
Research Director, Horizons Program
Population Council, seconded from PATH
Martha Ainsworth, PhD (Discussant)
Lead Economist and Coordinator
Health and Education Evaluation Independent Evaluation Group
The World Bank
Mary Lyn Field-Nguer, MSN, FNP (Discussant)
Director, Global HIV/AIDS Programs/Washington
John Snow, Inc.
Kent Glenzer, PhD (Discussant)
Director, Impact Measurement and Learning Team
CARE USA
Jonathan Mwiindi (Discussant)
Director, Kijabe HIV/AIDS Relief Program, Kenya
HIV/AIDS Program Officer
Ecumenical Pharmaceutical Network
Mead Over, PhD (Discussant)
Presentation
Senior Fellow
Center for Global Development
4:00 – 4:15 Break
4:15 – 5:45 Combined Panel
Moderated discussion with all panelists and audience
Summary of key issues and way forward
|